|
Preliminary Program |
|
|
Stream 1: Opening Ceremony and Keynote Forum |
|
|
Part 1: Opening Ceremony Part 2: Keynote Forum |
|
|
Stream 2: Frontiers in Drug Discovery Science |
|
|
Session 201: Pharmacogenomics and Personalized Medicine |
Session 202: Epigenetics in Drug Discovery |
|
Session 203: Pharmacology and Drug Mechanisms of Action |
Session 204: Network Medicine and Polypharmacology |
|
Session 205: Frontiers in Inflammation and Immuno-oncology |
Session 206: The Microbiome-based Drug Discovery |
|
Stream 3: Emerging Drug Discovery Technologies |
|
|
Session 301: Artificial Intelligence (AI) and Machine Learning in Drug Discovery |
Session 302: CRISPR-Cas Gene Editing |
|
Session 303: Novel Analytical Technology in Drug Discovery |
Session 304: High-Throughput Screening Technology |
|
Session 305: Phenotypic Drug Discovery |
Session 306: Cryo-EM in Drug Discovery |
|
Session 307: Microfluidics and Lab-on-a-Chips |
Session 308: Omics Technologies |
|
Stream 4: Novel Drug Targets |
|
|
Session 401: Targeting Transcription Factors |
Session 402: Targeting Degraders & Molecular Glues |
|
Session 403: Targeting Protein-Protein Interactions |
Session 404: Targeting Kinases |
|
Session 405: Targeting RNA |
Session 406: Epigenetic Targets |
|
Session 407: Undruggable Targets |
Session 408: Bacterial and Viral Targets |
|
Session 409: Immunomodulatory Targets |
Session 410: Ion Channel and GPCR Targets |
|
Stream 5: Drug Discovery Chemistry |
|
|
Session 501: Drug Design and Synthesis |
Session 502: Hit Identification |
|
Session 503: Computer Aided Drug Design |
Session 504: Fragment & Structured Based Drug Discovery |
|
Session 505: Hit-to-Lead Optimization |
Session 506: ADME-Tox Profiling |
|
Stream 6: New Drug R & D Pipelines |
|
|
Session 601: New Anti-cancer Drug R & D Pipelines |
Session 602: CNS and Neurodegenerative Disorders Drugs R & D Pipelines |
|
Session 603: Emerging Infectious Diseases Drug R & D Pipelines |
Session 604: Circulatory System and Respiratory System Diseases Drug R & D Pipelines |
|
Session 605: Diabetes, Obesity and Metabolic Diseases Drug R & D Pipelines |
Session 606: Inflammation and Immunological Diseases Drug R & D Pipelines |
|
Session 607: psychiatric and Mental Drug R & D Pipelines |
Session 608: Neglected Tropical Diseases and Orphan Diseases Drug R & D Pipelines |
|
Stream 7: New Biotherapy Discovery |
|
|
Session 701: Immune Checkpoints and Immunotherapy |
Session 702: CAR T, Bispecific T-Cell Engagers and NK Cell Therapies |
|
Session 703: RNAi and Gene Therapy |
Session 704: Therapeutic Antibodies and Vaccines |
|
Session 705: Oncolytic Viral Therapy |
Session 706: Cytokine Therapies |
|
Session 707: Microbiome-Based Therapies |
Session 708: Exosome Therapeutics |
|
Stream 8: Natural Products and Traditional Medicine |
|
|
Session 801: New Natural Products & Herbal Medicine Drug Discovery |
Session 802: Novel Green Synthesis Strategies and Technologies of Natural Products |
|
Session 803: Personalized Medicine and Natural Products |
Session 804: Marine Natural Products |
|
Session 805: Evidence-Based Traditional Medicine |
Session 806: The Integration of Modern and Traditional Medicine |
|
Stream 9: Pharmaceutical Manufacturing |
|
|
Session 901: Digitalization and Smart Manufacturing for Pharmaceuticals |
Session 902: Continuous Bioprocessing for Drug Manufacturing |
|
Session 903: 3D Printing in Drug Manufacturing |
Session 904: Novel Cell Lines, Cell Cultures and Purification Technologies |
|
Session 905: QC/QA & Bioanalysis |
Session 906: New Biosimilars and Biobetters |
| Session 907: CMO/CRO, Outsourcing and Integrative Services | |
|
Stream 10: Posters and Exhibition |
|
|
Zone 1: Posters |
Zone 2: Exhibition |
|
Stream 11: Social and Cultural Activities |
|
|
Activity 1: Welcome Banquet and Art Performance |
Activity 2: Lecture Tours to Campus |
|
Activity 2: Field Trip to Industrial Park or Companies |
Activity 4: Local Impression Tech-Tour |
© 2003-2025 All rights reserved by BITeomics |
|